期刊文献+

CXCL9和Smad3在新疆维吾尔族寻常性银屑病患者皮损中的表达 被引量:1

The Expression of CXCL9 and Smad3 in Psoriasis Vulgaris of Xinjiang Uyghur Patients
下载PDF
导出
摘要 目的比较新疆维吾尔族寻常性银屑病患者皮损及正常维吾尔族人群皮肤中CXCL9和Smad3的表达差异。方法 Envision免疫组化法分别检测新疆维吾尔族寻常性银屑病患者皮损及正常人皮肤中CXCL9和Smad3的表达情况。结果与维吾尔族人群正常皮肤相比,CXCL9在寻常性银屑病皮损中的表达明显增加,主要以真皮乳头顶端为主,且差异具有明显统计学意义(χ2=17.874,P<0.01);Smad3在寻常性银屑病皮损中主要表达于细胞浆和细胞核,与正常皮肤中Smad3的表达相比,χ2=0.000,P>0.05,差异无统计学意义。结论新疆维吾尔族寻常性银屑病皮损中CXCL9蛋白表达升高,通过JAK/STAT信号通路在寻常性银屑病的炎症反应中发挥重要作用。 Objection To compare the expression differences of CXCL9 and Smad3 between psoriasis vulgaris lesions of Xinjiang .Uygur patients and normal skin of Uygur people. Methods Using envision immuno-histochemical method to detect the expression of CXCL9 and Smad3 in skin lesion of Xinjiang Uygur psoriasis vulgaris pa- tients and in normal skin, respectively. Results In comparison with normal skin, the expression of CXCL9 in the skin lesions of Xinjiang Uyghur psoriasis vulgaris patients was obviously increased, mainly expressing in the top of the dermal papilla and the basal layer, and differences were statistically significant (X^2 = 17. 874,P 〈 0. 01 ). The expression of Smad3 was significantly down-regulated compared to normal skin tis- sues, and mainly located in the cytoplasm and cell nucleus with no statistically significant difference (X^2 = 0. 000,P 〉 0. 05 ). Conclusion The expression of CXCL9 in the lesions of Xinjiang Uygur psoriasis vulgar- is patients were up-regulated, and may contribute to the inflammatory response in paoriasis vulgaris via the JAK/STAT signal pathway.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第3期242-245,共4页 The Chinese Journal of Dermatovenereology
关键词 银屑病 寻常性 维吾尔族 JAK/STAT CXCL9 SMAD3 Psoriasis, vulgaris Uyghur JAK/STAT CXCL9 Smad3
  • 相关文献

参考文献11

  • 1Ma YQ, Luo D, Zhao ZF, et al. The expression and signficance of GA- TA3 in lesions of psoriasis vugaris Uyghur patients jn Xinjiang [ J ]. J Clin Dermatol, 2014,43 ( 7 ) : 409 - 411.
  • 2Chen SC, de Groot M, Kinsley D, et al. Expression of chemokine recep- tor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions[ J]. Arch Dermatol Res,2010,302(2) : 113 - 123.
  • 3Dilm6-Carreras E, Martln-Ezquerra G, S6nchez-Regan. M,et al. Serum prolactin levels in psoriasis and correlation with cutaneous disease activi- ty[ J]. Clin Exp Dermatol,2011, 36( 1 ) :29 -32.
  • 4E1-Khateeb EA, Zuel-Fakkar NM, Eid SM, et al. Prolactin level is sig- nificantly elevated in lesional skin of patients with psoriasis [ J ]. Int J Dermato1,2011, 50 ( 6 ) :693 - 696.
  • 5Lun SW,Wong CK,Ko FW,et al. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma [ J 1 - J Clin Im- muno1,2006,26 : 145 - 152.
  • 6Goebeler M, Toksoy A, Spandau U,et al. The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions[ J ]. J Pathol, 1998, 184(1) :89 -95.
  • 7Han G1, Williams CA, Salter K, et al. A role for TGFbeta signaling in the pathogenesis of psoriasis [ J ]. J Invest Dermatol, 2010,130 ( 2 ) : 371 - 377.
  • 8Yu H, Mrowietz U, Seifert O. Downregulation of SMAD2, 4 and 6 mR- NA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin[ J ]. Acta Derm Venereol, 2009, 89 (4) :351 -356.
  • 9Ulloa L, Doody J, Massagu6 J, et al. Inhibition of transforming growth fac- tor-beta/SMAD signalling by the interferon-gamma/STAT pathway [ J ]. Nature, 1999, 397(6721 ) :710 -713.
  • 10叶超然,何威,吴军,黎智,杨进清,黄海,何云志,王儒鹏.寻常性银屑病皮损表皮中TGF-β受体活化Smad蛋白表达的检测[J].临床皮肤科杂志,2008,37(1):17-19. 被引量:5

二级参考文献20

  • 1王莉,霍艳英,张开泰,王莹,项晓琼,胡迎春,余刚,李刚,米粲,吴德昌.Smad7对Smad2、Smad3、Smad4核转位的抑制作用[J].生物技术通讯,2005,16(2):128-130. 被引量:6
  • 2孙芸,何威,张国威,黎智,何云志,黄海,林自华,郑红.寻常型银屑病皮损区表皮Smurf2表达及其意义[J].第三军医大学学报,2005,27(20):2060-2062. 被引量:3
  • 3孙芸,何威,张国威,何云志,黄海,郑红.寻常性银屑病皮损表皮中Smad7表达的检测及其临床意义[J].临床皮肤科杂志,2006,35(1):3-5. 被引量:5
  • 4孙芸,何威,张国威,何云志,黄海,吴军,李顺碧,郑红.Smad泛素化调节因子1在寻常性银屑病皮损区的表达[J].中华皮肤科杂志,2006,39(3):164-165. 被引量:3
  • 5Nockowski P,Szepietowski JC,Ziarkiewicz M,et al.Serum concentrations of transforming growth factor beta 1 in patients with psoriasis vulgaris[J].Acta Dermatovenerol Croat,2004,12(1):2-6.
  • 6Flisiak I,Porebski P,Flisiak R,et al.Plasma transforming growth factor beta1 as a biomarker of psoriasis activity and treatment efficacy[J].Biomarkers,2003,8(5):437-443.
  • 7Massagué J,Seoane J,Wotton D.Smad transcription factors[J].Genes Dev,2005,19(23):2783-2810.
  • 8Ebisawa T,Fukuchi M,Murakami G,et al.Imamura T and Miyazono K.Smurf1 Interacts with Transforming Growth Factor-βType I Receptor through Smad7 and Induces Receptor Degradation[J].J Biol Chem,2001,276(16):12477-12480.
  • 9Duff EK,Clarke AR.Smad4:a potent tumour suppressor[J].Br J Cancer,1998,78(12):1615-1619.
  • 10Mehra A,Wrana JL.TGF-beta and the Smad signal transduction pathway[J].Biochem Cell Biol,2002,80(5):605.

共引文献4

同被引文献32

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部